Expertise
A Smart Approach to AI
Medical imaging in clinical trials reduces costs and improves time to market, but many biopharma companies leave these benefits on the table.
Medical imaging in clinical trials reduces costs and improves time to market, but many biopharma companies leave these benefits on the table.
QMENTA’s AI Platform Selected for the CAVS-MS Multiple Sclerosis Biomarker...
UK neurologists publish details of mildly affected or recovering Covid-19...
Contrast-enhanced ultrasound scans revealed patterns in the lung not typically...
Quantitative computer-aided analysis of chest CT (QCT) scans can help...
Is Radiology Ready For A Post COVID-19 Imaging Surge? ...
Young and middle-aged people, barely sick with COVID-19, Are Dying...
Radiology Revenue Could Drop by Up to 70 Percent During...
Most chest x-rays of COVID-19 patients are ‘normal’ Almost...